Evidence map›Paper›PMID 41744892›Full record

ArticleCurrent oncology (Toronto, Ont.)2026

BLOSSOM Dietary Habits and 1-Year Intravesical Recurrence in High-Risk Non-Muscle-Invasive Bladder Cancer Treated with BCG.

Carlo Buonerba, Raffaele Baio, Felice Crocetto, Dario Bruzzese, Francesco Del Giudice, Antonio Nacchia, Francesco Chiancone, Concetta Ingenito, Oriana Strianese, Antonio Verde and 24 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Carlo BuonerbaOncology Unit, "Andrea Tortora" Hospital, ASL Salerno, 84016 Pagani, Italy.
Raffaele BaioDepartment of Urology, Umberto I, Nocera Inferiore, 84014 Salerno, Italy.ORCID 0000-0002-3157-0845
Felice CrocettoUrology and Andrology Unit, Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-4315-7660
Dario BruzzeseDepartment of Public Health, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0001-9911-4646
Francesco Del GiudiceDepartment of Maternal-Infant and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I Hospital, 00161 Rome, Italy.ORCID 0000-0003-3865-5988
Antonio NacchiaSant'Andrea Hospital, 00189 Rome, Italy.ORCID 0000-0002-3985-1991
Francesco ChianconeDepartment of Urology, A.O.R.N. Antonio Cardarelli Hospital, 80131 Naples, Italy.ORCID 0000-0001-8648-3557
Concetta IngenitoOncology Unit, "Andrea Tortora" Hospital, ASL Salerno, 84016 Pagani, Italy.
Oriana StrianeseOncology Unit, "Andrea Tortora" Hospital, ASL Salerno, 84016 Pagani, Italy.
Antonio VerdeOncology Unit, "Andrea Tortora" Hospital, ASL Salerno, 84016 Pagani, Italy.
Ferdinando CostabileOncology Unit, "Andrea Tortora" Hospital, ASL Salerno, 84016 Pagani, Italy.
Luca ScafuriOncology Unit, "Andrea Tortora" Hospital, ASL Salerno, 84016 Pagani, Italy.ORCID 0000-0002-7410-8300
Roberto SanseverinoDepartment of Urology, Umberto I, Nocera Inferiore, 84014 Salerno, Italy.
Elena SorrentinoDepartment of Agricultural, Environmental and Food Sciences (DiAAA), University of Molise, Via Francesco de Sanctis snc, 86100 Campobasso, Italy.ORCID 0000-0002-3570-7642
Vittorio RiccioP.O. "Santissima Maria della Pietà" Hospital, 80026 Casoria, Italy.
Dalila CarinoDepartment of Maternal-Infant and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I Hospital, 00161 Rome, Italy.ORCID 0009-0007-4043-6625
Margherita BertoniDepartment of Maternal-Infant and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I Hospital, 00161 Rome, Italy.
Federica MonacoDepartment of Anesthesia, San Paolo Hospital ASL Napoli 1 Centro, 80125 Naples, Italy.ORCID 0000-0002-5986-3594
Paolo VerzeDepartment of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Baronissi, 84081 Salerno, Italy.
Teresa Di LauroS.C. Oncologia Clinica Sperimentale Uro-Ginecologica, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", 80131 Naples, Italy.
Sisto PerdonàUrology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy.
Celeste ManfrediUnit of Urology, Department of Woman Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
Antonio RuffoDipartimento di Medicina e di Scienze della Salute "Vincenzo Tiberio", 86100 Campobasso, Italy.
Gabriele BarbatoDepartment of Anesthesia and Intensive Care, "Anastasia Guerriero" Hospital, Caserta Local Health Authority, Marcianise, 81100 Caserta, Italy.
Serena RizzanoFondazione "Peppino Scoppa", Angri, 84012 Salerno, Italy.
Sara RizzanoFondazione "Peppino Scoppa", Angri, 84012 Salerno, Italy.
Armando PisapiaFondazione "Peppino Scoppa", Angri, 84012 Salerno, Italy.
Marina PisapiaFondazione "Peppino Scoppa", Angri, 84012 Salerno, Italy.
Rossella Di TrolioUnit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, 80131 Naples, Italy.
Emanuela SergianniSchool of Medicine, Vita-Salute San Raffaele University, 20132 Milan, Italy.
Giuseppe RomeoDepartment of Urology, A.O.R.N. Antonio Cardarelli Hospital, 80131 Naples, Italy.
Francesca CappuccioOncology Unit, "Andrea Tortora" Hospital, ASL Salerno, 84016 Pagani, Italy.
Gennaro SostoGeneral Directorate, ASL Salerno, 84134 Salerno, Italy.
Giuseppe Di LorenzoOncology Unit, "Andrea Tortora" Hospital, ASL Salerno, 84016 Pagani, Italy.

Funding

AstraZeneca (Italy) (Protocol No. 1100/15/10/2020)Fondazione Peppino Scoppa (Grant No. 302/2023)liberal grant from the Bank of Italy (Banca d'Italia Eurosystem) (Protocol No. 2203159/23)
6 · The paper itself

Abstract

Evidence on modifiable post-diagnosis factors influencing outcomes after intravesical Bacillus Calmette-Guérin (BCG) therapy for high-risk non-muscle-invasive bladder cancer (NMIBC) is limited. In this exploratory, feasibility-focused prospective multicenter cohort (March 2023-November 2024), BCG-naïve patients completed repeated interviewer-administered 24 h dietary recalls; prespecified food groups, selected foods, and nutrients were screened for associations with 1-year intravesical recurrence using Firth's penalized logistic regression adjusted a priori for age, sex, and total energy intake, with false discovery rate control within each exposure family. Forty-six patients were enrolled; 41 had evaluable recurrence status, including 8 recurrences (19.5%). Participants were predominantly overweight (mean body mass index (BMI) 28.4 kg/m

Indexed as

24 h dietary recalldietFirth logistic regressionFOODCONSintravesical BCGMediterranean Adequacy Indexnon-muscle-invasive bladder cancernutrient densityrecurrence

Identifiers

PMID41744892
PMCPMC12939331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.